SEC Tracker
Get the app

Axogen AXGN

William P. Mr. Burke (AXGN) Chief Financial Officer Karen Smith reported selling 10,000 shares worth $150,000. This insider selling activity signals potential bearish sentiment from company leadership, which may raise concerns for investors about the near-term outlook for the stock.

William P. Mr. Burke, insider filing for AXGN

Form
4
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Axogen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. Angiodynamics ANGO public float $436M, Nov 30, 2025
  2. Orthofix Medical OFIX public float $440M, Jun 30, 2025
  3. Delcath Systems DCTH public float $420M, Jun 30, 2025
  4. Ceribell CBLL public float $417M, Jun 30, 2025
  5. Pulse Biosciences PLSE public float $394M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.